In the ever evolving landscape of systemic immune mediated diseases, an increased
awareness regarding the associated cardiovascular system impairment has been noted in …

Sjögren's syndrome (SS) is a multifactorial systemic autoimmune disease of unknown
aetiology characterised by a wide spectrum of different clinical manifestations and scattered …

Primary Sjögren's syndrome (SS) is a chronic systemic autoimmune disorder affecting
primarily perimenopausal women. The key histopathological features of SS are mouth and …

Primary Sjögren's syndrome (pSS) is an autoimmune disease, associated with a high risk of
lymphoma. Mounting evidence suggests that cardiovascular morbidity and mortality are …

Abstract About 25–50% of patients with primary Sjögren's disease (SjD) take
hydroxychloroquine (HCQ). Although it is widely prescribed, and recommended in …

Hydroxychloroquine (HCQ) has been used to treat Sjögren's disease (SjD) patients.
However, there are no studies evaluating drug adherence through HCQ blood levels …

Hydroxychloroquine exposure reduces the risk of cardiovasular disease events in patients with
hypertension or diabetes mellitus Page 1 Clinical and Experimental Rheumatology 2022 …

Objective To evaluate the efficacy and safety of hydroxychloroquine sulfate (HCQ) in the
treatment of low risk phospholipase A2 receptor (PLA2R)-associated membranous …

Aim This study aimed to evaluate the long‐term survival, causes of death, and prognostic
factors in Chinese patients with primary Sjögren syndrome (pSS). Methods We included …

Objective To evaluate the efficacy and safety of hydroxychloroquine sulfate (HCQ) in the
treatment of low risk phospholipase A2 receptor (PLA2R)-associated membranous …